Medical Writing Good Pharma Transparency and the healthcare industry: The Sun is shining
mew-150pxjpg

Volume 22, Issue 4 - Good Pharma

Transparency and the healthcare industry: The Sun is shining

Abstract

The demand for greater transparency in financial relationships between the healthcare industry and healthcare professionals is increasing globally, and has led to establishing government regulations and professional guidelines for detailed reporting and public disclosure of these relationships. In the US, under the Physician Payment Sunshine Act, the government requires an annual report on payments and transfers of value made by healthcare product manufacturers to physicians and teaching hospitals. The implementation rules for this act were announced in February 2013, with data collection beginning on 1 August 2013. The first reports are due to the US government by March 2014, and public disclosure of the data will begin in September 2014. Concerns are growing within the healthcare industry regarding these new transparency requirements, and the likely unintended consequences, such as reduced participation of physicians in industry-sponsored clinical trials and delays in publication of clinical trial data.

Download the full article

References

  1. Jacobs A. Rebuilding an enduring trust in medicine: a global mandate: presidential address. American Heart Association Scientific Sessions 2004. Circulation 2005;111:3494–8.
  2. Bosch X, Esfandiari B, McHenry L. Challenging medical ghostwriting in US courts. PLoS Med 2012;9(1):e1001163. Doi:10.1371/journal.pmed.1001163 10.1371/journal.pmed.1001163. Epub 2012 Jan 24.
  3. Woolley K. Goodbye Ghostwriters! How to work ethically and efficiently with professional medical writers. Chest 2006;130:921–3.
  4. Norris R, Bowman A, Fagan JM, Gallagher ER, Geraci AB, Gertel A, et al. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin 2007;23:1837–40.
  5. Graf C, Battisti W, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, Field EA, et al. Research methods and reporting: publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330. Doi: 10.1136/bmj.b4330.
  6. Mansi B, Clark J, David F, Gesell TM, Glasser S, Gonzales J, et al. Recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc 2012;87:424–9.
  7. ISMPP. Org [Internet]. Briarcliff Manor (NY): International Society for Medical Publication Professionals. ISMPP certification program: certified medical publication professional (CMPP) credential. 2009 [cited 2013 Aug 17] Available from: http://www.ismpp.org/
  8. PhRMA.org. [Internet] Washington (DC): Pharmaceutical Researchers and Manufacturers of America. Principles for responsible data sharing. EFPIA and PhRMA release joint principles for responsible clinical trial data sharing to benefit patients. 2013 Jul 22 [cited 2013 Aug 17] Available from: http://www.phrma.org/
  9. Advamed.org. [Internet]. Washington, DC: Advanced Medical Technology Association. Code of ethics on interactions with healthcare professionals 2009 [updated 2013 Jan 25; cited Aug 17] Available from: http://www.ismpp.org/
  10. PhRMA.org. [Internet] Washington (DC): Pharmaceutical Researchers and Manufacturers of America. Principals on conduct of clinical trials: communication of clinical trial results. 2009 Oct 1 [updated 2013 Apr 8; cited 2013 Aug 17]. Available from: http://www.phrma.org/
  11. Patient Protection and Affordable Care Act. 111 Congress HR 3590 2010:111–148. 2010. [updated 2010 Jan 5; cited 2013 Aug 17]. Available from: http://www.gpo.gov/fdsys/pkg/BILLS-111hr3590enr/pdf/BILLS-111hr3590enr.pdf
  12. Lauer K, Patel M, Pepitone K. Physician Payment Sunshine Act: Potential implications for medical publication professionals. AMWA J 2012;27(1):7–9.
  13. CMS.gov [Internet]. Baltimore (MD): Centers for Medicare and Medicaid Services. National physicians payment transparency program [updated 2013 May 22; cited 2013 Aug 17]. Available from: http://www.cms.gov/
  14. Agrawal S, Brennan N, Budetti P. The Sunshine Act – effects on physicians. N Engl J Med 2013;368(22):2054–7.
  15. ISMPP Suggested Approaches for Sunshine Act Interpretation and Implementation for Publication Support Requirements. [cited 2013 Aug 16] Available from: http://www.ismpp.org/assets/docs/Inititives/Sunshine_Act/ismpp%20task%20force%20document_final_081313.pdf
  16. Parisi G. Coalition leaders highlight agency/publisher challenges to ensure accuracy and understanding of sunshine reports. 2013 Jun 19 [cited 2013 Aug 17]. In: Cohealthcom.org [Internet] New York: Coalition for Healthcare Communication [about 1 screen]. Available from: http://www.cohealthcom.org/
  17. ISRreports.com. [Internet]. Cary (NC): Industry Standard Research. Sunshine Act pharma impact—changes in US physician behavior. [updated 2013 Feb 26, cited 2013 Aug 17] Available from: http://www.isrreports.com/
  18. Jack A. Bring me sunshine: EU drug companies make payments to doctors public. BMJ 2013;347:f4342.
  19. American Society of Clinical Oncology. American Society of Clinical Oncology policy for relationships with companies: background and rationale. J Clin Oncol 2013;31:2037–42.

Search

Articles

Good pharma
Message from the President
Transparency and the healthcare industry: The Sun is shining
Sunshine spreading across the Atlantic and over Europe
Bad karma
If a misinformed voice speaks out in the wilderness and no one refutes it, does it make a sound? A call to advocacy
The Big Pharma conspiracy theory
Editorial: Pharmaism
Legal remedies for medical ghostwriting: Imposing fraud liability on guest authors of ghostwritten articles
A decade of change: A new ISMPP has arrived
Selling evidence over the counter: Do community pharmacists engage with evidence-based medicine?
Good regulatory practice and the role(s) of a regulatory affairs professional
Profile: An interview with Dr Gustavo A. Silva on the concept of public health in medical writing and translation
AuthorAID: An international service and chance to serve
India as a hub for ethical and evidence-based medical communications
Providing value for medicines in older people
In the Bookstores
Journal Watch
The Webscout
Regulatory Writing
Medical Communications
Manuscript Writing
Out On Our Own
Erratum
The Light Stuff

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

  • Victoria White (Tampa, Florida, USA) Email: MEW@emwa.org
show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: